📅12–15 May, Barcelona
🔗 More: https://info.orcid.org/event/dataverse-community-meeting/
#OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
https://bmjopen.bmj.com/content/16/5/e104128
The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.
It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.
OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
https://www.openpharma.blog/wp-content/uploads/2021/02/2020-01-15-Charter-of-Open-Pharma.pdf
Also see the OpenPharma home page.
https://www.openpharma.blog/
Open Science aims to fight misinformation and improve trust in scientific research; it encourages the reliability and accessibility of evidence, reduces inequalities through the democratisation of scientific knowledge and focuses scientific endeavours on issues of societal significance. As a multisponsor collaboration committed to driving positive change, Open Pharma has a multifaceted vision for scientific research publications funded by pharmaceutical companies (‘company research publications’) that aligns strongly with Open Science tenets. This new vision statement outlines our forward-looking principles for company research publications, both for short-term attainment (‘immediate’) and long-term commitment (‘ultimate’). Together, the principles provide a framework for positive collective action by all stakeholders involved in the development and dissemination of peer-reviewed company research publications. Underpinned by our central commitment to transparency for company research publications, we outline goals for: universal access to these publications; provision of peer-reviewed plain language summaries of the publications to aid comprehension among non-specialist readers; leveraging author and institutional metadata to advance transparency, discoverability and research impact; working towards FAIR (Findability, Accessibility, Interoperability, and Reuse) data principles through cross-sector consensus and action, and disclosure of patient involvement in research and its reporting to support transparency and encourage a research ecosystem attuned to patient centricity. We call on all stakeholders to realise the Open Pharma Vision and achieve an open and trusted future for company research publications that will ultimately advance patient care and improve global health.
ما هي فوائد منصة ORCID للباحث؟
توفر المنصة فوائد كثيرة للباحث مثل زيادة الظهور الأكاديمي وتسهيل تتبع المنشورات، وزيادة فرص التعاون الدولي، وأيضًا تعزيز الهوية البحثية الرقمية.
أكمل القراءة:
https://blog.ajsrp.com/?p=183503
#ORCID #زيادة_الظهور_الأكاديمي #فرص_التعاون_الدولي
#رواد_النشر_العلمي
إيميل: [email protected]
واتساب: 00970569831045
أرسل بحثك: ajsrp.com/send
#ORCID is growing! In 2025, we welcomed 125 new organizations and launched two new consortia in Africa. 🌍
Explore the 2025 Annual Report:
https://doi.org/10.23640/07243.31846192
We’re making researcher data more useful 🛠️
In 2025, #ORCID launched:
✅ The Featured Works section
✅ 13 new work types for Arts & Humanities
✅ Expanded Community Trust Network
See our full 2025 impact in the new Annual Report:
https://doi.org/10.23640/07243.31846192
📢 Call for Proposals: Global Participation Fund!
Now through 1 May, we are accepting applications for the GPF. We’re on a mission to build research equity by funding ORCID Communities of Practice in countries where participation has traditionally been low.
✅ ORCID membership is NOT required to apply.
Learn more and submit your proposal:
https://info.orcid.org/global-participation-program/global-participation-fund/